Cargando…
Potential Therapeutic Strategies for Skeletal Muscle Atrophy
The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy not only seriously reduces people’s quality of life and increases morbidity and mortality, but also causes a huge socioeconomic burden. To date, no effective treatment has been developed for skeletal muscle a...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854691/ https://www.ncbi.nlm.nih.gov/pubmed/36670909 http://dx.doi.org/10.3390/antiox12010044 |
_version_ | 1784873184559890432 |
---|---|
author | Huang, Li Li, Ming Deng, Chunyan Qiu, Jiayi Wang, Kexin Chang, Mengyuan Zhou, Songlin Gu, Yun Shen, Yuntian Wang, Wei Huang, Ziwei Sun, Hualin |
author_facet | Huang, Li Li, Ming Deng, Chunyan Qiu, Jiayi Wang, Kexin Chang, Mengyuan Zhou, Songlin Gu, Yun Shen, Yuntian Wang, Wei Huang, Ziwei Sun, Hualin |
author_sort | Huang, Li |
collection | PubMed |
description | The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy not only seriously reduces people’s quality of life and increases morbidity and mortality, but also causes a huge socioeconomic burden. To date, no effective treatment has been developed for skeletal muscle atrophy owing to an incomplete understanding of its molecular mechanisms. Exercise therapy is the most effective treatment for skeletal muscle atrophy. Unfortunately, it is not suitable for all patients, such as fractured patients and bedridden patients with nerve damage. Therefore, understanding the molecular mechanism of skeletal muscle atrophy is crucial for developing new therapies for skeletal muscle atrophy. In this review, PubMed was systematically screened for articles that appeared in the past 5 years about potential therapeutic strategies for skeletal muscle atrophy. Herein, we summarize the roles of inflammation, oxidative stress, ubiquitin-proteasome system, autophagic-lysosomal pathway, caspases, and calpains in skeletal muscle atrophy and systematically expound the potential drug targets and therapeutic progress against skeletal muscle atrophy. This review focuses on current treatments and strategies for skeletal muscle atrophy, including drug treatment (active substances of traditional Chinese medicine, chemical drugs, antioxidants, enzyme and enzyme inhibitors, hormone drugs, etc.), gene therapy, stem cell and exosome therapy (muscle-derived stem cells, non-myogenic stem cells, and exosomes), cytokine therapy, physical therapy (electroacupuncture, electrical stimulation, optogenetic technology, heat therapy, and low-level laser therapy), nutrition support (protein, essential amino acids, creatine, β-hydroxy-β-methylbutyrate, and vitamin D), and other therapies (biomaterial adjuvant therapy, intestinal microbial regulation, and oxygen supplementation). Considering many treatments have been developed for skeletal muscle atrophy, we propose a combination of proper treatments for individual needs, which may yield better treatment outcomes. |
format | Online Article Text |
id | pubmed-9854691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98546912023-01-21 Potential Therapeutic Strategies for Skeletal Muscle Atrophy Huang, Li Li, Ming Deng, Chunyan Qiu, Jiayi Wang, Kexin Chang, Mengyuan Zhou, Songlin Gu, Yun Shen, Yuntian Wang, Wei Huang, Ziwei Sun, Hualin Antioxidants (Basel) Review The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy not only seriously reduces people’s quality of life and increases morbidity and mortality, but also causes a huge socioeconomic burden. To date, no effective treatment has been developed for skeletal muscle atrophy owing to an incomplete understanding of its molecular mechanisms. Exercise therapy is the most effective treatment for skeletal muscle atrophy. Unfortunately, it is not suitable for all patients, such as fractured patients and bedridden patients with nerve damage. Therefore, understanding the molecular mechanism of skeletal muscle atrophy is crucial for developing new therapies for skeletal muscle atrophy. In this review, PubMed was systematically screened for articles that appeared in the past 5 years about potential therapeutic strategies for skeletal muscle atrophy. Herein, we summarize the roles of inflammation, oxidative stress, ubiquitin-proteasome system, autophagic-lysosomal pathway, caspases, and calpains in skeletal muscle atrophy and systematically expound the potential drug targets and therapeutic progress against skeletal muscle atrophy. This review focuses on current treatments and strategies for skeletal muscle atrophy, including drug treatment (active substances of traditional Chinese medicine, chemical drugs, antioxidants, enzyme and enzyme inhibitors, hormone drugs, etc.), gene therapy, stem cell and exosome therapy (muscle-derived stem cells, non-myogenic stem cells, and exosomes), cytokine therapy, physical therapy (electroacupuncture, electrical stimulation, optogenetic technology, heat therapy, and low-level laser therapy), nutrition support (protein, essential amino acids, creatine, β-hydroxy-β-methylbutyrate, and vitamin D), and other therapies (biomaterial adjuvant therapy, intestinal microbial regulation, and oxygen supplementation). Considering many treatments have been developed for skeletal muscle atrophy, we propose a combination of proper treatments for individual needs, which may yield better treatment outcomes. MDPI 2022-12-26 /pmc/articles/PMC9854691/ /pubmed/36670909 http://dx.doi.org/10.3390/antiox12010044 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Huang, Li Li, Ming Deng, Chunyan Qiu, Jiayi Wang, Kexin Chang, Mengyuan Zhou, Songlin Gu, Yun Shen, Yuntian Wang, Wei Huang, Ziwei Sun, Hualin Potential Therapeutic Strategies for Skeletal Muscle Atrophy |
title | Potential Therapeutic Strategies for Skeletal Muscle Atrophy |
title_full | Potential Therapeutic Strategies for Skeletal Muscle Atrophy |
title_fullStr | Potential Therapeutic Strategies for Skeletal Muscle Atrophy |
title_full_unstemmed | Potential Therapeutic Strategies for Skeletal Muscle Atrophy |
title_short | Potential Therapeutic Strategies for Skeletal Muscle Atrophy |
title_sort | potential therapeutic strategies for skeletal muscle atrophy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854691/ https://www.ncbi.nlm.nih.gov/pubmed/36670909 http://dx.doi.org/10.3390/antiox12010044 |
work_keys_str_mv | AT huangli potentialtherapeuticstrategiesforskeletalmuscleatrophy AT liming potentialtherapeuticstrategiesforskeletalmuscleatrophy AT dengchunyan potentialtherapeuticstrategiesforskeletalmuscleatrophy AT qiujiayi potentialtherapeuticstrategiesforskeletalmuscleatrophy AT wangkexin potentialtherapeuticstrategiesforskeletalmuscleatrophy AT changmengyuan potentialtherapeuticstrategiesforskeletalmuscleatrophy AT zhousonglin potentialtherapeuticstrategiesforskeletalmuscleatrophy AT guyun potentialtherapeuticstrategiesforskeletalmuscleatrophy AT shenyuntian potentialtherapeuticstrategiesforskeletalmuscleatrophy AT wangwei potentialtherapeuticstrategiesforskeletalmuscleatrophy AT huangziwei potentialtherapeuticstrategiesforskeletalmuscleatrophy AT sunhualin potentialtherapeuticstrategiesforskeletalmuscleatrophy |